ORCHPHARMA

Orchid Pharma Limited

IN Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
1012.549988
Fair value
917.301922
Next-week expectancy
Undecided 48.37%
Sharemaestro

ORCHPHARMA Chart Pack

Orchid Pharma Limited

Exchange
NSI
Latest week
10 Jul 2026
Close
1012.549988
Fair value
917.301922
Next-week expectancy
Undecided 48.37%
Generated
16 Jul 2026 18:10
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, ORCHPHARMA rose 78.63%, moving from 566.85 to 1,012.55. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 41.24 and has improved across the 12-week window. Market Dynamics is 1.51 on the latest week. Next-week expectancy is undecided at 48.37% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
1,012.55
12-Week Change
78.63%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.37%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
41.24
Market Dynamics
1.51

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
1,012.55
12-Week Change
78.63%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.37%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
41.24
Market Dynamics
1.51

Over the latest 12 completed weeks ending 2026-07-10, ORCHPHARMA rose 78.63%, moving from 566.85 to 1,012.55. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 41.24 and has improved across the 12-week window. Market Dynamics is 1.51 on the latest week. Next-week expectancy is undecided at 48.37% based on similar historical setup states.

Industry Peers

India equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
UNICHEMLAB Unichem Laboratories Limited NSI 10 Jul 2026 475.95 687.20 454.05 638.75 34.21%
RPGLIFE RPG Life Sciences Limited NSI 10 Jul 2026 2392.16 2889.00 2362.45 2856.90 19.43%
IOLCP IOL Chemicals and Pharmaceuticals Limited NSI 10 Jul 2026 143.70 177.90 143.00 171.06 19.04%
INDSWFTLAB Ind-Swift Laboratories Limited NSI 10 Jul 2026 215.10 248.00 212.85 246.44 14.57%
BETA BETA DRUGS LIMITED NSI 10 Jul 2026 2109.00 2395.00 1980.00 2366.80 12.22%
AKUMS AKUMS DRUGS AND PHARMA L NSI 10 Jul 2026 630.00 707.40 620.00 701.95 11.42%
HIKAL Hikal Limited NSI 10 Jul 2026 221.98 247.50 215.00 244.75 10.26%
SPARC Sun Pharma Advanced Research Company Limited NSI 10 Jul 2026 241.00 289.00 241.00 264.60 9.79%
SUVEN Suven Life Sciences Limited NSI 10 Jul 2026 327.60 370.80 308.50 357.85 9.23%
PGHL Procter & Gamble Health Limited NSI 10 Jul 2026 6371.00 6941.00 6202.50 6839.00 7.35%
GRANULES Granules India Limited NSI 10 Jul 2026 839.50 901.80 834.50 889.85 6.00%
INDOCO Indoco Remedies Limited NSI 10 Jul 2026 246.00 265.09 234.10 260.23 5.78%
NATCOPHARM NATCO Pharma Limited NSI 10 Jul 2026 940.00 997.30 919.90 984.10 4.69%
AMANTA AMANTA HEALTHCARE LIMITED NSI 10 Jul 2026 171.24 189.00 171.24 179.17 4.63%
ABBOTINDIA Abbott India Limited NSI 10 Jul 2026 26070.00 27350.00 26025.00 27165.00 4.20%
BLISSGVS Bliss GVS Pharma Limited NSI 10 Jul 2026 504.96 535.45 469.33 524.30 3.83%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.